newsfilter
← Latest News
GlobeNewswire·

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSXV:MDP) (OTCQX:MEDXF) (Frankfurt: P731) announced today that it is initiating immediate availability of Triamcinolone Hex